Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Bulfinch Snags 7K-SF Cambridge Office Property
Private real estate investment, development and management firm Bulfinch Cos. has acquired 1120 Massachusetts Avenue, a 7,200-square-foot office building at Harvard Square in Cambridge. The sales price was undisclosed.
The acquisition is the firm’s 13th property in Cambridge. Bulfinch plans to redevelop and reposition the asset as a first-class office, medical or biotech property, complete with a roof deck. The building has two stories above grade and one below, with floor-to-ceiling windows on the street providing high visibility. The property is nearby Harvard University, MIT, and is located along Boston’s MBTA red line.
“Cambridge is the global epicenter of life science, technology and medical research, and Bulfinch has committed to expanding our portfolio in this space,” said Eric Schlager, CEO at Bulfinch. “During this crucial time of combatting a global pandemic, we’re meeting the need for lab space among key researchers in biodiscovery. Not only does the presence of life science research enrich the Cambridge culture, it also positions the city as a strong investment location, as life science and biotechnology discoveries become increasingly imperative.”
For comments, questions or concerns, please contact David Cohen
- ◦Development